- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01545622
Surgeon Compared to Nuclear Radiology Readers for Tc-99m Sestamibi Scans for Parathyroid Disease
August 30, 2017 updated by: University of Arkansas
The purpose of this study is to analyze the findings of 30 surgeons and 30 nuclear radiologists of 61 individual thyroid scans.
The goal is to determine if surgeons are more prone to making a definitive diagnosis based on a given scan than a nuclear radiologist.
Accuracy of localization of the two groups will be analyzed.
A secure website has been designed to which the physician will be able to login and view and rate the quality of each image and make a localizing diagnosis.
Once they are finished, they will not be able to make any more changes, and their responses will be compared to the responses of their colleagues.
The results will be analyzed to find if there is a significant variation in the ratings between the surgeons and the nuclear radiologists as to the quality, location, and number of parathyroid glands, if any, on the scans.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
61
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72205
- University of Arkansas for Medical Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The study population will consist of 30 surgeons and 30 nuclear radiologists.
Description
Inclusion Criteria:
- Must be a surgeon or nuclear radiologist to be eligible read scans for this study.
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Analyze the findings of individual thyroid scans
Time Frame: 1 day
|
The results will be analyzed to find if there is a significant variation in the ratings between the surgeons and the nuclear radiologists as to the quality, location, and number of parathyroid glands, if any, on the scans.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 1, 2008
Primary Completion (ACTUAL)
September 1, 2016
Study Completion (ACTUAL)
September 1, 2016
Study Registration Dates
First Submitted
February 21, 2012
First Submitted That Met QC Criteria
March 1, 2012
First Posted (ESTIMATE)
March 7, 2012
Study Record Updates
Last Update Posted (ACTUAL)
August 31, 2017
Last Update Submitted That Met QC Criteria
August 30, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 104675
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parathyroid Disease
-
Shandong Linglong Yingcheng HospitalRecruitingIndocyanine Green | Total Thyroidectomy | Parathyroid Function Low Adverse Event | Parathyroid Glands--DiseasesChina
-
M.D. Anderson Cancer CenterRecruiting
-
University of ArkansasCompletedParathyroid DiseaseUnited States
-
M.D. Anderson Cancer CenterWithdrawnParathyroid Disease
-
University of ArkansasCompletedThyroid Disease | Parathyroid Disease | Endocrine GlandUnited States
-
M.D. Anderson Cancer CenterTerminated
-
Ito HospitalCompletedThyroid Disease | Parathyroid DiseaseJapan
-
David M. Schuster, MDCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPrimary Hyperparathyroidism | Parathyroid Gland Carcinoma | Parathyroid Gland Adenoma | Parathyroid Gland Atypical AdenomaUnited States
-
M.D. Anderson Cancer CenterCompletedParathyroid Carcinoma | Parathyroid NeoplasmUnited States